Mastek Limited Schedules Analyst and Institutional Investor Meet with Anand Rathi AIF on May 14, 2026

1 min read     Updated on 13 May 2026, 10:52 PM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

Mastek Limited has scheduled a single investor meet with Anand Rathi AIF on May 14, 2026, at 4:00 PM in Mumbai, under Regulation 30 of SEBI (LODR) Regulations, 2015. The in-person interaction will cover only industry and company-specific developments already in the public domain. The company has confirmed that no unpublished price sensitive information (UPSI) will be shared during the meeting. The schedule is subject to change due to exigencies on the part of the investor or the company.

powered bylight_fuzz_icon
40238503

*this image is generated using AI for illustrative purposes only.

Mastek Limited has notified the stock exchanges of a scheduled Analyst and Institutional Investor Meet, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The intimation, dated May 13, 2026, was filed by Company Secretary and Compliance Officer Reena Raje on behalf of the company.

Meeting Details

The company has arranged a one-to-one investor interaction with Anand Rathi AIF. The key details of the scheduled meet are as follows:

Parameter: Details
Date: May 14, 2026
Interaction With: Anand Rathi AIF
Nature of Meet: Single Investor Meet
Venue/Mode: Mumbai / In-Person
Timing: 4:00 PM
Discussion: Industry/Company-specific developments already in the public domain

Scope and Disclosures

Mastek has explicitly stated that the aforesaid meeting is a one-to-one investor interaction. The company has confirmed that no unpublished price sensitive information (UPSI) is proposed to be shared during the investor meet. Discussions will be confined to industry and company-specific developments that are already in the public domain.

The company has also noted that the schedule of the meeting may undergo change due to exigencies on the part of the investor or the company. The aforesaid information has been hosted on the company's website at www.mastek.com .

Historical Stock Returns for Mastek

1 Day5 Days1 Month6 Months1 Year5 Years
+0.30%-8.14%-1.34%-30.65%-33.18%-18.89%

Could the one-to-one meeting with Anand Rathi AIF signal a potential increase in institutional investment or a new strategic partnership for Mastek?

How might Mastek's upcoming investor interactions influence its stock liquidity and analyst coverage in the near term?

What key industry-specific developments in the IT services sector could Mastek be positioning itself to highlight to institutional investors in 2026?

Mastek Allots 3,442 Equity Shares Under Employee Stock Option Plan VII, Paid-Up Capital Rises

2 min read     Updated on 09 May 2026, 03:33 AM
scanx
Reviewed by
Suketu GScanX News Team
AI Summary

Mastek allotted 3,442 equity shares of Rs. 5 each under ESOP Plan VII on May 8, 2026, to eligible employees who exercised their vested options. The allotment increased the company's paid-up share capital from Rs. 15,49,86,700 to Rs. 15,50,03,910, with total issued shares rising to 3,10,00,782. The shares were allotted across three exercise price tranches — Rs. 5, Rs. 174, and Rs. 350 per share — and rank pari-passu with existing equity shares with no lock-in restrictions.

powered bylight_fuzz_icon
39823430

*this image is generated using AI for illustrative purposes only.

The Stakeholder's Relationship Committee of the Board of Directors of mastek approved and allotted 3,442 equity shares of Rs. 5 each (face value) on May 8, 2026, under the company's Employee Stock Option Plan VII (ESOP Plan VII). The allotment was made to eligible employees who had exercised their vested stock options. The newly issued shares rank pari-passu with the existing equity shares of the company in all respects, with no lock-in restrictions applicable.

Impact on Paid-Up Share Capital

Consequent to this allotment, Mastek's paid-up share capital has increased as detailed below:

Metric: Before Allotment After Allotment
Number of Equity Shares: 3,09,97,340 3,10,00,782
Face Value per Share: Rs. 5 Rs. 5
Total Paid-Up Share Capital: Rs. 15,49,86,700 Rs. 15,50,03,910

ESOP Plan VII — Allotment Details

The allotment was made pursuant to ESOP Plan VII, for which in-principle listing approvals were received from BSE Limited on October 8, 2013, and from the National Stock Exchange of India Limited on September 16, 2013, each covering up to 25,00,000 equity shares of Rs. 5 each. The disclosure has been made under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and Regulation 10(c) of the SEBI (Share Based Employee Benefits) Regulations, 2014.

The key details of the allotment are summarised below:

Parameter: Details
Date of Issue: May 8, 2026
Number of Shares Issued: 3,442
Par Value per Share: Rs. 5
ESOP Plan: ESOP Plan VII
Kind of Security: Equity Shares
Distinctive Numbers: 3,79,29,291 to 3,79,32,732
Lock-In: Not Applicable
Total Issued Shares After Issue: 3,10,00,782
Total Issued Share Capital After Issue: Rs. 15,50,03,910

Exercise Price and Premium Breakdown

The 3,442 shares were allotted across three tranches with varying exercise prices and premiums, as disclosed by the company:

No. of Equity Shares: Exercise Price per Share (Rs.) Premium per Share (Rs.)
2,981 5 0
175 174 169
286 350 345

The disclosure was filed by Reena Raje, Company Secretary & Compliance Officer (Membership No. A21440), on behalf of Mastek. The company's registered office is located at 804/805, President House, Opp. C. N. Vidyalaya, Near Ambawadi Circle, Ahmedabad – 380 006, Gujarat.

Historical Stock Returns for Mastek

1 Day5 Days1 Month6 Months1 Year5 Years
+0.30%-8.14%-1.34%-30.65%-33.18%-18.89%

How might Mastek's continued ESOP allotments under Plan VII impact employee retention and talent acquisition strategies in the competitive IT services sector going forward?

Given that a majority of the allotted shares (2,981) were issued at face value with zero premium, what does this suggest about the vintage and structure of Mastek's older ESOP tranches, and could this dilution pattern accelerate in future quarters?

How will the gradual increase in Mastek's paid-up share capital through recurring ESOP exercises affect its earnings per share (EPS) metrics and valuation multiples over the next fiscal year?

More News on Mastek

1 Year Returns:-33.18%